[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626907":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":26,"locations":31,"responsibleParty":51,"collaborators":26,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":26,"enrollmentInfo":63,"targetDuration":26,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":34,"whyStopped":26,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Casa di Cura Dott. Pederzoli","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"99mTc","ACTIVE_COMPARATOR","radioisotope technetium technique will be used for sentinel lymph node localization(99mTc)",[13],"Procedure: technetium 99 used as a tracer for sentinel lymph node",{"label":15,"type":16,"description":17,"interventionNames":18},"ICG","EXPERIMENTAL","indocyanine green fluorescent imaging technique will be used for sentinel lymph node localization (ICG)",[19],"Procedure: ICG used as a tracer for sentinel lymph node",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","ICG used as a tracer for sentinel lymph node","ICG used as a tracer for sentinel lymph node instead of technetium 99",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"technetium 99 used as a tracer for sentinel lymph node","technetium 99 used as a tracer for sentinel lymph node instead of ICG",[9],[32],{"facility":33,"status":34,"city":35,"state":36,"zip":26,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Ospedale P. Pederzoli Casa di Cura Privata S.p.A.","RECRUITING","Peschiera del Garda","Verona","Italy","IT",{"type":40,"coordinates":41},"Point",[42,43],10.68614,45.43912,{"lat":43,"lon":42},[46],{"name":47,"role":48,"phone":49,"phoneExt":26,"email":50},"Francesca Guerini, MD","CONTACT","+39 0456444193","urc@ospedalepederzoli.it",{"type":52,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100626907","evaluate-the-implementation-of-using-indocyanine-green-for-sentinel-lymph-node-mapping-in-breast-cancer-patients-100626907",false,"NCT07441733","Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients","INFLUENCE II - a Pilot Study for Implementation Identification of Sentinel Lymph Nodes in Breast Cancer Patients Through Non-invasively FLUorEsceNt Imaging Using indoCyaninE Green: a Pilot Study for Implementation","INFLUENCE II","Inclusion Criteria:\n\n* Clinically node-negative, DCIS or invasive stage T1-T3 breast cancer confirmed by biopsy\n* Preoperative axillary ultrasound to confirm clinical node-negative status\n* Indication for breast cancer surgery with SLNB via axillar incision\n* Written informed consent according to national regulations\n\nExclusion Criteria:\n\n* Patients \\\u003C 18 years old.\n* Indication for breast cancer surgery with SLNB via mastectomy incision\n* Known allergy for ICG, intravenous contrast or iodine\n* History of axillary lymph node dissection\n* Pregnancy or breast-feeding\n* Psychological, familial, sociological or geographical factors that could potentially hamper compliance with the study protocol","FEMALE","18 Years",{"count":64,"type":65},40,"ESTIMATED","INTERVENTIONAL",[68],"NA","This single-institution pilot study uses a pre- and post-implementation design to evaluate the implementation of ICG fluorescent imaging for sentinel lymph node biopsy (SLNB) in an Italian hospital.",[71],"Breast Cancer",[73,74,9,15],"breast cancer","lymph node","2026-05-06",{"date":77,"type":78},"2026-05-11","ACTUAL",{"date":80,"type":78},"2024-11-07",{"date":82,"type":65},"2026-10",{"name":5,"class":6},1]